Empyrean Capital Partners, LP - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 112 filers reported holding THERAVANCE INC in Q1 2015. The put-call ratio across all filers is 57.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Empyrean Capital Partners, LP ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$37,300,000
+89.4%
3,538,858
+29.0%
1.38%
+42.3%
Q3 2015$19,690,000
-48.4%
2,742,302
+29.8%
0.97%
-45.7%
Q2 2015$38,180,000
+34.9%
2,112,892
+17.4%
1.78%
+26.7%
Q1 2015$28,296,000
+19.0%
1,800,000
+7.1%
1.41%
+3.9%
Q4 2014$23,770,0001,679,8891.35%
Other shareholders
THERAVANCE INC shareholders Q1 2015
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders